The intervention-therapeutic effect of lipiodol-arsenic trioxide emulsion for primary hepatic carcinoma / 介入放射学杂志
Journal of Interventional Radiology
; (12)2006.
Article
en Zh
| WPRIM
| ID: wpr-682951
Biblioteca responsable:
WPRO
ABSTRACT
Objective To discuss the short-term clinical effect including functional change of lipiodol- arsenic trioxide emulsion on the primary hepatic carcinoma.Methods Fifty-two patients undergone arterial chemoemblization were selected and then randomly divided into two groups:treatment group(n=27)and control group(n=25).Patients in treatment group were treated with lipiodol-arsenic trioxide,while those in control group treated with mitomycin,epirubicin,cisplatin or lipiodol.Clinical symptoms and six liver function parameters were observed and analized.Results The clinical symptoms of patients in treatment group improved much better than those in control group,and the liver function impairment of patients in treatment group also decreased more than those in control group.Conclusions Lipiodol-arsenic trioxide is an effective and safe intervention-therapeutic embolization material for primary hepatic carcinoma.
Texto completo:
1
Banco de datos:
WPRIM
Idioma:
Zh
Año:
2006
Tipo del documento:
Article